NCPDP | Jotup

NCPDP Announces Highlights from its 2024 Annual Conference, "Innovation Starts Here"

Retrieved on:

Donnerstag, Mai 9, 2024

NCPDP, TIM, Innovation, Conference, Intelligence, Science, Pharmacist, MBA, Meeting

SCOTTSDALE, Ariz. , May 8, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the evolving role of pharmacists as an integral part of the patient care team" said Lee Ann Stember, President & CEO of NCPDP. "The goal is to relieve pharmacists of administrative burdens so they can operate at the top of their license and receive payment for their clinical services." The Annual Conference included riveting keynote speakers, topical educational sessions, big reveals on member and industry award recipients, and networking opportunities.

Key Points:

Highlights Include Keynotes on Future of Pharmacy and Technology Innovation, Newly Elected Board Members, Award Recipients and More
SCOTTSDALE, Ariz. , May 8, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here.
The Annual Conference included riveting keynote speakers, topical educational sessions, big reveals on member and industry award recipients, and networking opportunities.
Mindy D. Smith, R.Ph., M.H.A., TabulaRasa Healthcare/ExactCare Pharmacy, was appointed Vice Chair of the NCPDP Board of Trustees.
NCPDP's 2025 Annual Technology & Business Conference will be held May 5-7, 2025, at the Westin Kierland Resort & Spa in Scottsdale, Arizona.

NCPDP Announces its 2024 Champion Award Recipient at #NCPDP24

Retrieved on:

Mittwoch, Mai 8, 2024

Work Group, Task force, Pharmacy, Pharmacist, NCPDP, Policy, Conference, ONC, Patient safety, Government, Physician, HIT, Health, HITAC, Emerging, Meeting, Therapy, Pharmaceutical industry

SCOTTSDALE, Ariz., May 8, 2024 /PRNewswire-PRWeb/ -- Today at its Annual Technology & Business Conference, NCPDP announced its 2024 Champion Award recipient, Shelly Spiro, Executive Director at Pharmacy HIT Collaborative and President and CEO of Spiro Consulting. NCPDP's Champion Award recognizes outstanding accomplishments or work to improve patient care by actively supporting NCPDP members and its initiatives.

Key Points:

SCOTTSDALE, Ariz., May 8, 2024 /PRNewswire-PRWeb/ -- Today at its Annual Technology & Business Conference, NCPDP announced its 2024 Champion Award recipient, Shelly Spiro, Executive Director at Pharmacy HIT Collaborative and President and CEO of Spiro Consulting.
NCPDP's Champion Award recognizes outstanding accomplishments or work to improve patient care by actively supporting NCPDP members and its initiatives.
NCPDP President & CEO Lee Ann Stember stated, "We are pleased to present this award to Shelly, a long-time participant of NCPDP, Work Group Co-Chair and Leader of multiple Task Groups.
For real-time updates during the conference, follow @NCPDP on X, NCPDP on LinkedIn, or join the discussion using the hashtag: #NCPDP24.

NCPDP Foundation's Inaugural Pulido Award Honors Namesake's Legacy of Pharmacy Innovation

Retrieved on:

Montag, Mai 6, 2024

SCOTTSDALE, Ariz., May 6, 2024 /PRNewswire-PRWeb/ -- A true changemaker for the pharmacy profession and an industry leader in vaccine intelligence were honored by the NCPDP Foundation this past Sunday at the President & CEO Leadership Appreciation Dinner, which takes place during NCPDP's Annual Technology & Business Conference.

Key Points:

Charles Pulido and STChealth, represented by Strategic Advisor Tom Groom, were honored with the first-ever NCPDP Foundation Charles Pulido, R.Ph.
The award honors the Foundation grant that most fully optimized the vision and purpose of the NCPDP Foundation during the prior year.
Excellence Award was given for the first time to its namesake, Charles Pulido, who is a co-founder of NCPDP, and to STChealth , who led efforts to operationalize NCPDP's National Facilitator Model .
Groom also shared a memory from an NCPDP black tie event where he met Pulido for the first time.

FDB to Explore the Pharmacist's Role in Fitting a Patient's Genes to a Drug at NCPDP Annual Conference

Retrieved on:

Donnerstag, Mai 2, 2024

First Databank, Meeting, FDB, NCPDP, Conference, SAN

SOUTH SAN FRANCISCO, Calif., May 2, 2024 /PRNewswire/ -- Pharmacist leaders from FDB (First Databank, Inc.) will enlighten attendees at the NCPDP 2024 Annual Technology & Business Conference about one of the fastest growing and most promising new areas of precision medicine: pharmacogenomics (PGx). They will explore how standardized procedures, which can help drive a cohesive and consistent approach to PGx testing, and implementation of established and emerging technologies can better integrate pharmacists into the process of leveraging PGx data to improve prescribing decisions.

Key Points:

SOUTH SAN FRANCISCO, Calif., May 2, 2024 /PRNewswire/ -- Pharmacist leaders from FDB (First Databank, Inc.) will enlighten attendees at the NCPDP 2024 Annual Technology & Business Conference

DTx Alliance Releases Report Supporting Health Plans Through DTx Integration and Workflow Challenges

Retrieved on:

Donnerstag, April 11, 2024

Caregiver, Workflow, PBM, Single-frequency network, Pharmacy, Communication, Patient, NCPDP, Research, DTA, NDC, Medical device

Arlington, VA, April 11, 2024 (GLOBE NEWSWIRE) -- A new report was released by Digital Therapeutics Alliance (DTA) to support health plans efforts to adopt digital therapeutic products (DTx).

Key Points:

Arlington, VA, April 11, 2024 (GLOBE NEWSWIRE) -- A new report was released by Digital Therapeutics Alliance (DTA) to support health plans efforts to adopt digital therapeutic products (DTx).
Incorporating DTx products into standard practice has been an expressed challenge for all stakeholders, ranging from provider systems and health plans, to pharmacies, distributors, and pricing compendia.
At that time, health plans were unsure of DTx product placement in pharmacy or medical benefit pathways.
Point-of-Care-Partners was selected as the research partner on this project due to their extensive experience working with health plans on workflow issues.

NCPDP Announces Emmy-Winning David Pogue to Deliver Keynote Address for Its 2024 Annual Conference "Innovation Starts Here"

Retrieved on:

Dienstag, Februar 20, 2024

SCOTTSDALE, Ariz., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today that David Pogue, the Emmy Award-winning CBS Sunday Morning correspondent, NOVA host, and former New York Times columnist, will give a captivating keynote address at its 2024 Annual Technology & Business Conference, "Innovation Starts Here". The Annual Conference, which will be held May 6-8, 2024, at the Westin Kierland Resort & Spa in Scottsdale, Arizona, is expected to draw more than 700 attendees representing a broad cross-section of pharmacy and other healthcare-related industry segments.

Key Points:

SCOTTSDALE, Ariz., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today that David Pogue, the Emmy Award-winning CBS Sunday Morning correspondent, NOVA host, and former New York Times columnist, will give a captivating keynote address at its 2024 Annual Technology & Business Conference, "Innovation Starts Here" .
"Mr. Pogue will bring a diverse, interdisciplinary perspective that will motivate NCPDP's Annual Conference attendees to think differently about the future of healthcare technology."
NCPDP's 2024 Annual Technology & Business Conference "Innovation Starts Here" is open to all healthcare industry stakeholders.
For real-time updates before and during the event, follow @NCPDP on X, NCPDP on LinkedIn, or join the discussion using NCPDP's 2024 Annual Technology & Business Conference hashtag: #NCPDP24.

NCPDP Foundation Awards $150,000 Grant to RxLive to Automate Tracking of Physician Adoption of Pharmacists' Clinical Recommendations

Retrieved on:

Mittwoch, Dezember 20, 2023

SCOTTSDALE, Ariz., Dec. 20, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $150,000 grant to RxLive, a provider of population health pharmacy solutions, to automate, track and quantify providers' response to pharmacists' clinical recommendations to measure the value of pharmacist-led interventions. RxLive will use NCPDP standards along with RxLive's expansive network across both acute and ambulatory care settings, including its platform integration with the Surescripts network and Health Gorilla Health Information Exchange, to pilot a process that can be used for bidirectional communication of patient-specific clinical information that will allow pharmacists to consult with patients, share their clinical recommendations with physicians, and track adoption of pharmacists' recommendations - to better coordinate care and improve patient health outcomes.

Key Points:

SCOTTSDALE, Ariz., Dec. 20, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $150,000 grant to RxLive , a provider of population health pharmacy solutions, to automate, track and quantify providers' response to pharmacists' clinical recommendations to measure the value of pharmacist-led interventions.
"The NCPDP Foundation grant to RxLive has the potential to document at scale the measurable value pharmacists bring to patients and the patient care team," explained J.W.
The goal of the project is to quantify and analyze clinical interactions between pharmacists and patients and how often providers take action as a result of the pharmacist's clinical recommendations.
RxLive will introduce a natural language processing (NLP) interface to ease adoption of the Sig Format.

FDB Vela™ Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance

Retrieved on:

Mittwoch, Dezember 6, 2023

EHR, First Databank, SAN, Organization, Risk, NCPDP, National Council, Certification, Patient, HITRUST, FDB, Azure, API, Pharmacy, Architecture, Medical device

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2023 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise decisions, announced today that its FDB Vela™ ePrescribing network, one of FDB's newest solutions, has earned HITRUST Risk-based, 2-year (r2) Certified status demonstrating the highest level of information protection assurance.

Key Points:

HITRUST Risk-based, 2-year (r2) Certified status demonstrates that FDB Vela has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk.
This achievement places FDB in an elite group of organizations worldwide that have earned this certification.
To achieve the HITRUST Risk-based, 2-year Certification, FDB Vela surpassed requirements across various comprehensive cybersecurity and data protection domains.
Individually, each element exceeds most other programs and collectively they make HITRUST Certification the most comprehensive, transparent, consistent and highest quality assessment available."

Xact Laboratories Announces Strategic Partnership with a national Switch to provide integrated PGx results at the point of prescription fulfillment

Retrieved on:

Mittwoch, November 29, 2023

CNED, Patient safety, Pharmacist, NCPDP, Laboratory, Patient, Medicine, Prescription, Workflow, Trustee, Partnership, Health, PBM, Pharmaceutical industry, Nursing, Switch

Xact integrates PGx results at the Switch for real-time medication guidance for providers and pharmacists.

Key Points:

Xact integrates PGx results at the Switch for real-time medication guidance for providers and pharmacists.
In addition, Xact's integration of PGx data at the Switch will drive improvements in health plan initiatives, formulary adherence, and beneficiary satisfaction.
Rob Todd, managing partner of Xact Laboratories, expressed his enthusiasm about the partnership, "We believe that every patient deserves personalized, evidence-based healthcare.
PGx testing is revolutionizing the healthcare industry by allowing providers to tailor prescription drug regimens to an individual's genetic makeup.

NCPDP Foundation Awards $79,000 Grant to Digital Therapeutics Alliance to Address Key Barrier for Patient Access to Clinically Validated Digital Therapeutic Products

Retrieved on:

Mittwoch, August 16, 2023

Single-frequency network, Pharmacy, Therapy, Workflow, CNED, Research, PBM, NCPDP, Patient, Trustee, Digital, Health care, Pharmaceutical industry

SCOTTSDALE, Ariz., Aug. 16, 2023 /PRNewswire-PRWeb/ -- The NCPDP Foundation Board of Trustees has awarded a $79,000 grant to Digital Therapeutics Alliance to research health plans' criteria for determining coverage pathways of DTx products and develop pharmacy and medical benefit workflows to illustrate how clinically validated digital therapeutic products can be integrated into benefit designs. The grant supports the NCPDP Foundation's strategic initiative to Expand Patient Access to Care in alignment with NCPDP's strategic goal to explore how standards can support a pharmacist's role in digital therapeutics. Findings from the research project will also include recommendations for enhancements to existing NCPDP standards or a new NCPDP standard to support DTx products.

Key Points:

The grant supports the NCPDP Foundation's strategic initiative to Expand Patient Access to Care in alignment with NCPDP's strategic goal to explore how standards can support a pharmacist's role in digital therapeutics.
We are excited to fund this research which can help improve patient access to clinically validated digital therapeutics and advance interoperability of data that supports prescription digital therapeutics.
"We are excited to fund this research which can help improve patient access to clinically validated digital therapeutics and advance interoperability of data that supports prescription digital therapeutics," explained J.W.
Jessica Hauflaire, Chief Operating Officer, Digital Therapeutics Alliance said, "We thank the NCPDP Foundation for their remarkable support in breaking down this significant barrier to patient access.